Evidence for Antigenic Seniority in Influenza A (H3N2) Antibody Responses in Southern China
A key observation about the human immune response to repeated exposure to influenza A is that the first strain infecting an individual apparently produces the strongest adaptive immune response. Although antibody titers measure that response, the interpretation of titers to multiple strains – from the same sera – in terms of infection history is clouded by age effects, cross reactivity and immune waning. From July to September 2009, we collected serum samples from 151 residents of Guangdong Province, China, 7 to 81 years of age. Neutralization tests were performed against strains representing six antigenic clusters of H3N2 influenza circulating between 1968 and 2008, and three recent locally circulating strains. Patterns of neutralization titers were compared based on age at time of testing and age at time of the first isolation of each virus. Neutralization titers were highest for H3N2 strains that circulated in an individual's first decade of life (peaking at 7 years). Further, across strains and ages at testing, statistical models strongly supported a pattern of titers declining smoothly with age at the time a strain was first isolated. Those born 10 or more years after a strain emerged generally had undetectable neutralization titers to that strain (<1∶10). Among those over 60 at time of testing, titers tended to increase with age. The observed pattern in H3N2 neutralization titers can be characterized as one of antigenic seniority: repeated exposure and the immune response combine to produce antibody titers that are higher to more ‘senior’ strains encountered earlier in life.
Vyšlo v časopise:
Evidence for Antigenic Seniority in Influenza A (H3N2) Antibody Responses in Southern China. PLoS Pathog 8(7): e32767. doi:10.1371/journal.ppat.1002802
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002802
Souhrn
A key observation about the human immune response to repeated exposure to influenza A is that the first strain infecting an individual apparently produces the strongest adaptive immune response. Although antibody titers measure that response, the interpretation of titers to multiple strains – from the same sera – in terms of infection history is clouded by age effects, cross reactivity and immune waning. From July to September 2009, we collected serum samples from 151 residents of Guangdong Province, China, 7 to 81 years of age. Neutralization tests were performed against strains representing six antigenic clusters of H3N2 influenza circulating between 1968 and 2008, and three recent locally circulating strains. Patterns of neutralization titers were compared based on age at time of testing and age at time of the first isolation of each virus. Neutralization titers were highest for H3N2 strains that circulated in an individual's first decade of life (peaking at 7 years). Further, across strains and ages at testing, statistical models strongly supported a pattern of titers declining smoothly with age at the time a strain was first isolated. Those born 10 or more years after a strain emerged generally had undetectable neutralization titers to that strain (<1∶10). Among those over 60 at time of testing, titers tended to increase with age. The observed pattern in H3N2 neutralization titers can be characterized as one of antigenic seniority: repeated exposure and the immune response combine to produce antibody titers that are higher to more ‘senior’ strains encountered earlier in life.
Zdroje
1. FrancisT 1960 On the doctrine of original antigenic sin. Proc Am Philos Soc 104 572 578
2. DavenportFMHennessyAVFrancisT 1953 Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med 98 641 656
3. DavenportFMHennessyAV 1956 A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine. J Exp Med 104 85 97
4. St. GrothSFWebsterR 1966 Disquisitions On Original Antigenic Sin: I. Evidence In Man. J Exp Med 124 331 345
5. KimJHSkountzouICompansRJacobJ 2009 Original antigenic sin responses to influenza viruses. J Immunol 183 3294 3301
6. WebsterRG 1966 Original antigenic sin in ferrets: the response to sequential infections with influenza viruses. J Immunol 97 177 183
7. WrammertJSmithKMillerJLangleyWAKokkoK 2008 Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453 667 671
8. HaydenFGPaleseP 2009 Influenza Virus. RichmanDDWhitleyRJHaydenFG Clinical Virology ASM Press 943 976
9. HayAJGregoryVDouglasARLinYP 2001 The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 356 1861 1870
10. SmithDJLapedesASde JongJCBestebroerTMRimmelzwaanGF 2004 Mapping the antigenic and genetic evolution of influenza virus. Science 305 371 376
11. ZimmerSMBurkeDS 2009 Historical perspective–Emergence of influenza A (H1N1) viruses. N Engl J Med 361 279 285
12. AngelovaLAShvartsmanYaS 1982 Original antigenic sin to influenza in rats. Immunology 46 183 188
13. HorsfallFLRickardER 1941 Neutralizing Antibodies in Human Serum After Influenza A: The Lack of Strain Specificity in the Immunological Response. J Exp Med 74 433 439
14. MossongJHensNJitMBeutelsPAuranenK 2008 Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5 e74
15. BodewesRde MutsertGvan der KlisFRMVentrescaMWilksS 2011 Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol 18 469 476
16. WeiC-JBoyingtonJCMcTamneyPMKongW-PPearceMB 2010 Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329 1060 1064
17. MillerRA 1996 The aging immune system: primer and prospectus. Science 273 70 74
18. CovelliVMoutonDDi MajoVBouthillierYBangraziC 1989 Inheritance of immune responsiveness, life span, and disease incidence in interline crosses of mice selected for high or low multispecific antibody production. J Immunol 142 1224 1234
19. WangTTTanGSHaiRPicaNPetersenE 2010 Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog 6 e1000796
20. WrammertJKoutsonanosDLiG-MEdupugantiSSuiJ 2011 Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 208 181 93
21. LesslerJCummingsDATReadJMWangSZhuH 2011 Location-specific patterns of exposure to recent pre-pandemic strains of influenza A in southern China. Nat Commun 2 423
22. SchwarzG 1978 Estimating the dimension of a model. Ann Stat 6 461 464
23. WoodSN 2006 Generalized additive models: an introduction with R Chapman & Hall/CRC
24. ChenC-houhUnwinA 2008 Handbook of Data Visualization Springer
25. KimuraM 1980 A Simple Method for Estimating Evolutionary Rates of Base Substitutions Through Comparative Studies of Nucleotide Sequences. J Mol Evol 16 111 120
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2012 Číslo 7
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- The Lectin Pathway of Complement Activation Is a Critical Component of the Innate Immune Response to Pneumococcal Infection
- Gastrointestinal Cell Mediated Immunity and the Microsporidia
- Polydnaviruses as Symbionts and Gene Delivery Systems
- Evidence for Antigenic Seniority in Influenza A (H3N2) Antibody Responses in Southern China